🔥🐔 BizChicken 🐔🔥
Companies Similar to Vincerx Pharma, Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Anixa Biosciences, Inc.
Chimeric Endocrine Receptor T-cell Technology, Anti-Viral Drug Candidates, Vaccines
Anixa Biosciences, Inc. is a biotechnology company focused on developing therapies and vaccines for oncology and infectious diseases, including novel CAR-T technologies for ovarian cancer and vaccines for breast and ovarian cancer.
Symbol: ANIX
Recent Price: $2.50
Industry: Biotechnology
CEO: Dr. Amit Kumar Ph.D.
Sector: Healthcare
Employees: 4
Address: 3150 Almaden Expressway, San Jose, CA 95118
Phone: 408 708 9808
Last updated: 2024-12-31
ABVC BioPharma, Inc.
ABV-1501, ABV-1504, ABV-1505, ABV-1703, ABV-1702, ABV-1601, ABV-1701 Vitargus
ABVC Bio Pharma, Inc., based in Fremont, California, is a clinical stage biopharmaceutical company developing drugs and medical devices to address unmet medical needs in the United States. The company is involved in developing therapies for conditions such as cancer, major depressive disorders, and attention deficit hyperactivity disorder.
Symbol: ABVC
Recent Price: $0.59
Industry: Biotechnology
CEO: Dr. Uttam Yashwant Patil Ph.D.
Sector: Healthcare
Employees: 16
Address: 44370 Old Warm Springs Boulevard, Fremont, CA 94538
Phone: 510 668 0881
Last updated: 2024-12-31
ORIC Pharmaceuticals, Inc.
ORIC-533, ORIC-944, ORIC-114
ORIC Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that discovers and develops therapies for the treatment of cancers, focusing on overcoming resistance in chemotherapy and immunotherapy. Their product candidates target various cancer resistance mechanisms, including prostate cancer and epidermal growth factor receptor mutations.
Symbol: ORIC
Recent Price: $8.17
Industry: Biotechnology
CEO: Dr. Jacob M. Chacko M.B.A., M.D.
Sector: Healthcare
Employees: 107
Address: 240 East Grand Avenue, South San Francisco, CA 94080
Phone: 650 388 5600
Last updated: 2024-12-31
Syndax Pharmaceuticals, Inc.
SNDX-5613, SNDX-6352 (axatilimab), Entinostat
Syndax Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for cancer treatment, including innovative candidates like SNDX-5613 and SNDX-6352. It collaborates with notable institutions like the National Cancer Institute and has a license agreement with Kyowa Hakko Kirin Co., Ltd.
Symbol: SNDX
Recent Price: $12.52
Industry: Biotechnology
CEO: Mr. Michael A. Metzger M.B.A.
Sector: Healthcare
Employees: 184
Address: 35 Gatehouse Drive, Waltham, MA 02451
Phone: 781 419 1400
Last updated: 2024-12-31
Vaccinex, Inc.
pepinemab
Vaccinex, Inc., a clinical-stage biotechnology company, focuses on developing targeted biotherapeutics for cancer, neurodegenerative diseases, and autoimmune disorders. Its lead product candidate, pepinemab, is in clinical trials for multiple serious conditions.
Contact | Contact | Careers | About | Careers | About | About | About | About | About | News | Events | About | About | ESG | About | About | About | About | About
Symbol: VCNX
Recent Price: $1.11
Industry: Biotechnology
CEO: Dr. Maurice Zauderer Ph.D.
Sector: Healthcare
Employees: 37
Address: 1895 Mount Hope Avenue, Rochester, NY 14620
Phone: 585 271 2700
Last updated: 2024-12-31
BioMarin Pharmaceutical Inc.
Vimizim
Bio Marin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Their products cater to conditions like mucopolysaccharidosis, phenylketonuria, Batten disease, and more.
About | Leadership | Directors | About | About | About | Locations | Contact | About | Careers | Careers | Benefits | Careers | Events | Careers | Careers | Careers | Careers | Careers | Careers | Locations | Careers | Careers | Careers | Careers | Jobs | Site Map | About | About | About | About | About | About | About | About
Symbol: BMRN
Recent Price: $65.45
Industry: Biotechnology
CEO: Mr. Alexander Hardy
Sector: Healthcare
Employees: 3401
Address: 770 Lindaro Street, San Rafael, CA 94901
Phone: 415 506 6700
Leadership
- Mark Enyedy,
- Alexander Hardy,
- Elaine J. Heron,
- G. Eric Davis, Executive Vice President, Chief Legal Officer
- Greg Friberg, Executive Vice President, Chief Research & Development Officer
- C. Greg Guyer, Executive Vice President, Chief Technical Officer
- Cristin Hubbard, Executive Vice President, Chief Commercial Officer
- Marni Kottle, Executive Vice President, Chief Corporate Affairs Officer
- Brian R. Mueller, Executive Vice President, Chief Financial Officer
- James Sabry, Executive Vice President, Chief Business Officer
- Amy Wireman, Executive Vice President, Chief People Officer
- Richard A. Meier,
- Elizabeth McKee Anderson,
- Barbara Bodem,
- Athena Countouriotis,
- Willard H. Dere,
- Maykin Ho,
- Robert J. Hombach,
- David E.I. Pyott,
Last updated: 2024-12-31
MEI Pharma, Inc.
Zandelisib
MEI Pharma, Inc. is a late-stage pharmaceutical company focused on developing and commercializing therapies for cancer treatment, including Zandelisib and Voruciclib.
About | About | About | Contact | Contact | Careers | Careers | Contact | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Site Map | Careers | Careers | Careers | About | About | About | About | About | Jobs | About
Symbol: MEIP
Recent Price: $2.45
Industry: Biotechnology
CEO: Mr. Justin J. File
Sector: Healthcare
Employees: 28
Address: 11455 El Camino Real, San Diego, CA 92130
Phone: 858 369 7100
Last updated: 2024-12-31
Nurix Therapeutics, Inc.
NX-2127, NX-5948, NX-1607, NX-0255
Nurix Therapeutics, Inc. is a biopharmaceutical company that focuses on developing small molecule therapies for cancer and immune disorders, with products targeting BTK and CBL-B proteins. The company collaborates with Gilead Sciences and Sanofi.
Symbol: NRIX
Recent Price: $18.64
Industry: Biotechnology
CEO: Dr. Arthur T. Sands M.D., Ph.D.
Sector: Healthcare
Employees: 284
Address: 1700 Owens Street, San Francisco, CA 94158
Phone: 415 660 5320
Last updated: 2024-12-31
Vaxcyte, Inc.
VAX-24
Vaxcyte, Inc. is a clinical-stage biotechnology company developing novel protein vaccines for preventing or treating bacterial infectious diseases. Key products include the VAX-24 pneumococcal conjugate vaccine and other candidates targeting antibiotic resistance and periodontitis.
Symbol: PCVX
Recent Price: $81.99
Industry: Biotechnology
CEO: Mr. Grant E. Pickering M.B.A.
Sector: Healthcare
Employees: 254
Address: 825 Industrial Road, San Carlos, CA 94070
Phone: 650 837 0111
Last updated: 2024-12-31
Vincerx Pharma, Inc.
VIP152
Vincerx Pharma, Inc. is a clinical-stage biopharmaceutical company focused on researching and developing therapies to address unmet medical needs for cancer treatment in the United States. Their lead product candidate, VIP152, is a cyclin-dependent kinase-9 inhibitor for advanced cancer.
Symbol: VINC
Recent Price: $0.33
Industry: Biotechnology
CEO: Dr. Ahmed M. Hamdy M.D.
Sector: Healthcare
Employees: 42
Address: 260 Sheridan Avenue, Palo Alto, CA 94306
Phone: 650 800 6676
Last updated: 2024-12-31
Vaxxinity, Inc.
UB-311, UB-312, UB-313, UB-612
Vaxxinity, Inc. is a biotechnology company focused on developing product candidates for neurology and coronavirus-related treatments, including Alzheimer's, Parkinson's disease, migraines, and SARS-CoV-2.
Symbol: VAXX
Recent Price: $0.00
Industry: Biotechnology
CEO: Ms. Mei Mei Hu J.D.
Sector: Healthcare
Employees: 57
Address: 1717 Main Street, Dallas, TX 75201
Phone: 254 244 5739
Last updated: 2024-11-08
Verve Therapeutics, Inc.
VERVE-101
Verve Therapeutics, Inc. is a genetic medicines company developing gene editing treatments for cardiovascular diseases, primarily through its lead product VERVE-101.
Symbol: VERV
Recent Price: $5.54
Industry: Biotechnology
CEO: Dr. Sekar Kathiresan M.D.
Sector: Healthcare
Employees: 255
Address: 500 Technology Square, Cambridge, MA 02139
Phone: 617 603 0070
Leadership
- Andrew Ashe, President, Chief Operating Officer and General Counsel
- Victoria Bartlett, Vice President, Program and Alliance Management
- Dan Balian, Associate Director, Supply Chain Management
- Allen Barrett, Director, Corporate Counsel
Last updated: 2024-12-31
Vor Biopharma Inc.
VOR33
Vor Biopharma, Inc. is a clinical-stage company focused on developing engineered hematopoietic stem cell (e HSC) therapies for cancer patients, with a leading product, VOR33, in phase 1/2 trials for AML and other hematological malignancies.
About | Vision/Values | About | Leadership | Directors | About | About | Contact | Contact | News | Careers | About | About | About
Symbol: VOR
Recent Price: $1.19
Industry: Biotechnology
CEO: Dr. Robert Ang M.B.A., M.D., MBBS
Sector: Healthcare
Employees: 168
Address: 100 Cambridgepark Drive, Cambridge, MA 02140
Phone: 617 655 6580
Leadership
- Robert Ang, MBBS, MBA, President and Chief Executive Officer
- Eyal Attar, MD, Chief Medical Officer
- Tirtha Chakraborty, PhD, Chief Scientific Officer
- Han Choi, MD, LLM, Chief Financial Officer
- John King, MBA, Chief Commercial Officer and Head of Business Development
- Tania Philipp, Chief People Officer
- David Phillips, MBA, Senior Vice President, Head of Quality
- Samir Vattompadam, MS, Senior Vice President, Portfolio Strategy and Program Management
- Daniella Beckman, Board of Directors
- David Lubner, Board of Directors
- Bill Lundberg, MD, Board of Directors
- Fouad Namouni, MD, Board Of Directors
- Matthew R. Patterson, Chairman, Board of Directors
- Josh Resnick, MD, Board of Directors
Last updated: 2024-12-31
Verrica Pharmaceuticals Inc.
VP-102, VP-103
Verrica Pharmaceuticals Inc. develops and commercializes treatments for skin diseases in the United States, including products for molluscum contagiosum and warts. The company collaborates with Torii Pharmaceutical Co., Ltd., and Lytix Biopharma AS for further development and commercialization efforts.
Symbol: VRCA
Recent Price: $0.70
Industry: Biotechnology
CEO: Mr. Ted White
Sector: Healthcare
Employees: 100
Address: 44 West Gay Street, West Chester, PA 19380
Phone: 484 453 3300
Last updated: 2024-12-31
Verastem, Inc.
VS-6766
Verastem, Inc. is a biopharmaceutical company focused on developing and commercializing drugs for cancer treatment, with products such as VS-6766 and trials like RAMP 201 and 202 targeting various cancer types.
Symbol: VSTM
Recent Price: $3.67
Industry: Biotechnology
CEO: Mr. Daniel W. Paterson
Sector: Healthcare
Employees: 73
Address: 117 Kendrick Street, Needham, MA 02494
Phone: 781 292 4200
Last updated: 2024-12-31
VYNE Therapeutics Inc.
FCD105, FMX114, VYN201, VYN202
VYNE Therapeutics Inc. is a pharmaceutical company specializing in developing therapeutics for immuno-inflammatory conditions. Key products include FCD105 for acne vulgaris, FMX114 for atopic dermatitis, and BET inhibitors VYN201 and VYN202 for skin and other immuno-inflammatory diseases.
Symbol: VYNE
Recent Price: $3.19
Industry: Biotechnology
CEO: Mr. David T. Domzalski
Sector: Healthcare
Employees: 10
Address: 520 U.S. Highway 22, Bridgewater, NJ 08807
Phone: 800 775 7936
Last updated: 2024-12-31
X4 Pharmaceuticals, Inc.
mavorixafor
X4 Pharmaceuticals, Inc. is a late-stage clinical biopharmaceutical company dedicated to the development and commercialization of novel therapeutics for rare diseases, with its lead product mavorixafor in advanced clinical trials.
Symbol: XFOR
Recent Price: $0.81
Industry: Biotechnology
CEO: Dr. Paula Ragan Ph.D.
Sector: Healthcare
Employees: 127
Address: 61 North Beacon Street, Boston, MA 02134
Phone: 857 529 8300
Last updated: 2024-12-31
Xencor, Inc.
Monoclonal Antibody and Cytokine Therapeutics
Xencor, Inc. is a clinical-stage biopharmaceutical company specializing in the discovery and development of engineered monoclonal antibody and cytokine therapeutics for treating cancer and autoimmune diseases.
About | ESG | Contact | Careers | Careers | About | Events | About | About | About | Contact | Management | About | Directors | About | About | About | About | About | About | About | About | About | About | About | About | About | About | About | About | About | Careers
Symbol: XNCR
Recent Price: $23.71
Industry: Biotechnology
CEO: Dr. Bassil I. Dahiyat Ph.D.
Sector: Healthcare
Employees: 280
Address: 111 West Lemon Avenue, Monrovia, CA 91016
Phone: 626 305 5900
Last updated: 2024-12-31
Nuvectis Pharma, Inc.
NXP800, NXP900
Nuvectis Pharma, Inc., is a biopharmaceutical company that focuses on developing precision medicines for treating serious unmet medical needs in oncology. It is working on products like NXP800, a heat shock factor 1 pathway inhibitor, and NXP900, a drug candidate targeting Proto-oncogene c-Src and YES1 kinases.
Symbol: NVCT
Recent Price: $5.14
Industry: Biotechnology
CEO: Mr. Ron Bentsur M.B.A.
Sector: Healthcare
Employees: 13
Address: 1 Bridge Plaza, Fort Lee, NJ 07024
Phone: 201 614 3150
Last updated: 2024-12-31
Ventyx Biosciences, Inc.
VTX958
Ventyx Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing small molecule product candidates for the treatment of inflammatory diseases and autoimmune disorders. Key products include VTX958 for immune-mediated diseases, VTX002 for ulcerative colitis, and VTX2735 for systemic inflammatory diseases.
Symbol: VTYX
Recent Price: $2.23
Industry: Biotechnology
CEO: Dr. Raju S. Mohan Ph.D.
Sector: Healthcare
Employees: 73
Address: 662 Encinitas Boulevard, Encinitas, CA 92024
Phone: 760 593 4832
Last updated: 2024-12-31